Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | +25.00% | +11.11% | +42.86% |
Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
Mar. 14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+42.86% | 8.16M | |
+2.03% | 42.11B | |
+48.83% | 40.08B | |
+8.09% | 40B | |
-10.82% | 26.87B | |
+7.94% | 24.58B | |
-23.60% | 18.44B | |
+1.58% | 11.94B | |
+32.31% | 11.66B | |
+7.29% | 11.01B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Signs Development Deal for TPM-enhanced Ibuprofen Gel for US market; Shares Up 10%